Literature DB >> 18038699

Short-term corticosteroids and avascular necrosis: medical and legal realities.

Robert N Richards1.   

Abstract

Short-term corticosteroids (CSs), most commonly defined as short-term prednisone (STP) 40 to 60 mg or its equivalent, either tapered or level, prescribed over a few days to 3 weeks (total dose, 400-600 mg), often are used to treat acute and self-limiting diseases. Serious side effects, though uncommon, can occur; however, they receive little attention. The literature contains scattered case reports and legal cases that highlight the relationship between STP and avascular necrosis (AVN). The orthopedic literature finds that CSs are one of the most common causes of AVN. An Internet search of AVN identifies several commercial pages prepared for lawyers that describe references and supplies relevant to initiating lawsuits. Court cases consistently find that patients must be informed of treatment risks and options. Informed consent and thorough documentation are required when prescribing STP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18038699

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  3 in total

1.  Immunotherapeutics for autoimmune encephalopathies and dementias.

Authors:  Andrew McKeon
Journal:  Curr Treat Options Neurol       Date:  2013-12       Impact factor: 3.972

2.  Avascular necrosis after oral corticosteroids in otolaryngology: Case report and review of the literature.

Authors:  Patrick Kennedy; Ahmed Bassiouni; Alkis Psaltis; Jastin Antisdel; Joseph Brunworth
Journal:  Allergy Rhinol (Providence)       Date:  2016-01

Review 3.  Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper.

Authors:  Valerie Hox; Evelijn Lourijsen; Arnout Jordens; Kristian Aasbjerg; Ioana Agache; Isam Alobid; Claus Bachert; Koen Boussery; Paloma Campo; Wytske Fokkens; Peter Hellings; Claire Hopkins; Ludger Klimek; Mika Mäkelä; Ralph Mösges; Joaquim Mullol; Laura Pujols; Carmen Rondon; Michael Rudenko; Sanna Toppila-Salmi; Glenis Scadding; Sophie Scheire; Peter-Valentin Tomazic; Thibaut Van Zele; Martin Wagemann; Job F M van Boven; Philippe Gevaert
Journal:  Clin Transl Allergy       Date:  2020-01-03       Impact factor: 5.871

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.